// App-Quantinova.ai

4440 : Pharmacokinetics and Tolerability of Bosutinib in Asian Versus Non-Asian Patients with Philadelphia ChromosomePositive Leukemia

Researchers

Presenter

  • Poe-Hirr Hsyu

Principal Investigators

  • Karin Gogat

  • Ladan Duvillie

  • Virginia Kelly

  • Nadine Besson

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Thrombocytopenia

  • Neutropenia

  • Anemia

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Breakpoint Cluster Region

Drug/Treatment

  • Bosutinib

  • Nilotinib

  • dasatinib

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • open label

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved